Literature DB >> 11094258

Cell-cycle regulation in immunity, tolerance and autoimmunity.

D Balomenos1, C Martínez-A.   

Abstract

To trigger an effective immune response, lymphocytes must proliferate. In addition to their direct involvement in cell-cycle progression, cell-cycle regulators might thus control immune functions. Recent evidence suggests that these regulators are essential for T-cell function; we argue that their study will provide clues for dissecting anergy and tolerance mechanisms, as well as for intervention in autoimmune diseases.

Entities:  

Mesh:

Year:  2000        PMID: 11094258     DOI: 10.1016/s0167-5699(00)01748-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  20 in total

1.  Still waiting for the end. The promise of genomics and proteomics for autoimmune diseases.

Authors:  Dimitrios Balomenos; Carla Carvalho-Pinto; Carlos Martinez-A
Journal:  EMBO Rep       Date:  2002-02       Impact factor: 8.807

Review 2.  New approaches to investigating heterogeneity in complex traits.

Authors:  R Bomprezzi; P E Kovanen; R Martin
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

3.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Authors:  A Sturm; A Z A Leite; S Danese; K A Krivacic; G A West; S Mohr; J W Jacobberger; C Fiocchi
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

4.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.

Authors:  Andreas Sturm; Jugoh Itoh; James W Jacobberger; Claudio Fiocchi
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 6.  Anti-TNF-alpha therapies in systemic lupus erythematosus.

Authors:  Lang-Jing Zhu; Xiao Yang; Xue-Qing Yu
Journal:  J Biomed Biotechnol       Date:  2010-06-22

7.  Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.

Authors:  Giovanni Mantovani; Antonio Macciò; Clelia Madeddu; Loredana Mura; Giulia Gramignano; Maria Rita Lusso; Elena Massa; Miria Mocci; Roberto Serpe
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

8.  Baseline cell proliferation rates and response to UV differ in lymphoblastoid cell lines derived from healthy individuals of extreme constitution types.

Authors:  Sumita Chakraborty; Sunanda Singhmar; Dayanidhi Singh; Mahua Maulik; Rutuja Patil; Satyam Kumar Agrawal; Anushree Mishra; Madeeha Ghazi; Archana Vats; Vivek T Natarajan; Sanjay Juvekar; Bhavana Prasher; Mitali Mukerji
Journal:  Cell Cycle       Date:  2021-04-18       Impact factor: 4.534

9.  Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.

Authors:  Langjing Zhu; Xiao Yang; Weiying Chen; Xiaoyan Li; Yulian Ji; Haiping Mao; Jing Nie; Xueqing Yu
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 3.650

10.  CD4+CD25+ T regulatory cells from FIV+ cats induce a unique anergic profile in CD8+ lymphocyte targets.

Authors:  Jonathan E Fogle; Wayne A Tompkins; Mary B Tompkins
Journal:  Retrovirology       Date:  2010-11-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.